EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

In Silico Analysis for Sphingolipid Metabolism-Related Genes in Human Kidney Clear Cell Carcinoma Using The Cancer Genome Atlas.

Woo-Jae Park, Jee Young Park, Taeg Kyu Kwon, Jong-Wook Park, Shin Kim

Keimyung Medical Journal · 2020

DOI: 10.46308/kmj.2020.00101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Keimyung Medical Journal, 2020. Verfasst von Woo-Jae Park und 4 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Ministry of Science ICT and Future Planning, National Research Foundation of Korea.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sphingolipid rheostat concept states that the cellular fate is largely determined by various sphingolipid metabolites and the associated signaling pathways.Aberrant regulation of the sphingolipid metabolism-related components is closely associated with cancer survival and death, including aspects like cancer development, proliferation, progression, and response to anticancer drugs.In the present study, we investigated the expression and prognostic significance of the sphingolipid metabolism-related genes in clear cell renal cell carcinoma (ccRCC), the most common pathological subtype of kidney cancer, using an RNA-sequencing dataset of The Cancer Genome Atlas Kidney Clear Cell Carcinoma (TCGA KIRC) cohort.Expression levels of various sphingolipid metabolism-related genes were significantly altered in ccRCC tissues compared with those of normal solid tissues.Notably, the expression of B4GALNT1, BNIP3, DEGS1, GAL3ST1, S1PR4, SLC26A10, SMPDL3A, and SPHK1 was significantly upregulated, whereas the expression of B4GALT6, HPGD, LPAR1, SFTPB, ST6GALNAC5, and UGT8 was significantly downregulated in ccRCC tissues.Notably, among these significantly-altered sphingolipid metabolism-related genes, the Kaplan-Meier survival analyses showed that high expression levels of B4GALNT1, SLC26A10, and SPHK1 were associated with a poor prognosis of patients with ccRCC, whereas high expression levels of BNIP3, HPGD, and SMP-DL3A were associated with a better prognosis.Taken together, our study suggests that B4GALNT1, SLC26A10, SPHK1, BNIP3, HPGD, and SMPDL3A may be novel prognostic biomarkers and targets for a therapeutic strategy to improve the treatment of ccRCC.

Förderung

  • Ministry of Science ICT and Future Planning
  • National Research Foundation of Korea

Zitieren

APA

Park, W., Park, J. Y., Kwon, T. K., Park, J., & Kim, S. (2020). In Silico Analysis for Sphingolipid Metabolism-Related Genes in Human Kidney Clear Cell Carcinoma Using The Cancer Genome Atlas. Keimyung Medical Journal. https://doi.org/10.46308/kmj.2020.00101

Vancouver

Park W, Park JY, Kwon TK, Park J, Kim S. In Silico Analysis for Sphingolipid Metabolism-Related Genes in Human Kidney Clear Cell Carcinoma Using The Cancer Genome Atlas. Keimyung Medical Journal. 2020. doi:10.46308/kmj.2020.00101

BibTeX
@article{Park2020,
  author = {Park, Woo-Jae and Park, Jee Young and Kwon, Taeg Kyu and Park, Jong-Wook and Kim, Shin},
  title = {In Silico Analysis for Sphingolipid Metabolism-Related Genes in Human Kidney Clear Cell Carcinoma Using The Cancer Genome Atlas},
  journal = {Keimyung Medical Journal},
  year = {2020},
  doi = {10.46308/kmj.2020.00101}
}
Kostenlos starten →